Compare AU

Compare CURE vs. A200

Compare shares and ETFs on the ASX that you can trade on Pearler.

Global X S&P Biotech ETF

ASX

Buy

Buy

Overview
Industry & Region

Industry & Region


Country Exposure

CURE

A200

Australia

95.07 %

United States

3.04 %

New Zealand

1.41 %

United Kingdom of Great Britain and Northern Ireland

0.38 %

China

0.09 %


Industry Exposure

icon for key differences panel

Key differences

  • CURE has a higher allocation (100.00 %) in the Health Care sector than A200 (8.44 %).

  • The most popular industries that CURE is exposed to are Health Care (100.00 %), and Other (10.24 %). Comparatively, A200 is most exposed to Financials (34.23 %), Materials (17.97 %), and Health Care (8.44 %).

CURE

A200

Health Care

100.00 %

8.44 %

Other

10.24 %

3.24 %

Financials

34.23 %

Materials

17.97 %

Consumer Discretionary

7.51 %

Real Estate

6.84 %

Industrials

6.49 %

Energy

3.88 %

Communication Services

3.52 %

Consumer Staples

3.49 %

Information Technology

2.99 %

Utilities

1.40 %

Home